Metabolic Syndrome is a common condition whose prevalence is rising to epidemic proportions, having a significant impact on public health and the global economy.
The European Society of Cardiology (ESC) guidelines on the management of ventricular arrhythmias and prevention on SCD published in 2015 considered the new insights of the natural history of diseases predisposing to SCD.
Approximately half of the patients with signs and symptoms of heart failure have a left ventricular ejection fraction that is not markedly abnormal.
Ischaemic heart disease (e.g. coronary artery disease) is responsible for almost half of all cardiovascular deaths with around 30% of all deaths worldwide in cardiovascular diseases.
LIFE is a multicentre, open-label, prospective, observational study estimating health related QoL and functional endpoints with initiation of Ivabradine in older patients.
Increased heart rate (HR) is an independent risk factor for cardiovascular outcomes in chronic heart failure (HF).
